Role of biologics in severe eosinophilic asthma - focus on reslizumab.
Pelaia G, Vatrella A, Busceti MT, Gallelli L, Preianò M, Lombardo N, Terracciano R, Maselli R.
Pelaia G, et al. Among authors: preiano m.
Ther Clin Risk Manag. 2016 Jul 1;12:1075-82. doi: 10.2147/TCRM.S111862. eCollection 2016.
Ther Clin Risk Manag. 2016.
PMID: 27445482
Free PMC article.
Review.